RARE Insider Trading

Insider Ownership Percentage: 5.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $5,449,277.97

Ultragenyx Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at Ultragenyx Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ultragenyx Pharmaceutical Share Price & Price History

Current Price: $39.36
Price Change: Price Decrease of -0.24 (-0.61%)
As of 06/24/2024 05:00 PM ET

This chart shows the closing price history over time for RARE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ultragenyx Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/12/2024Karah Herdman ParschauerEVPSell9,806$45.00$441,270.0057,981View SEC Filing Icon  
6/10/2024Corsee D. SandersDirectorSell1,737$41.10$71,390.707,248View SEC Filing Icon  
4/18/2024Eric CrombezEVPSell142$44.10$6,262.2048,785View SEC Filing Icon  
3/11/2024Thomas Richard KassbergEVPSell11,509$49.93$574,644.37252,823View SEC Filing Icon  
3/7/2024Matthew K FustDirectorSell12,195$50.88$620,481.6014,860View SEC Filing Icon  
3/1/2024John Richard PinionInsiderSell4,173$53.76$224,340.4889,268View SEC Filing Icon  
3/1/2024Karah Herdman ParschauerEVPSell3,756$53.76$201,922.5667,340View SEC Filing Icon  
3/1/2024Theodore Alan HuizengaCAOSell341$53.76$18,332.1641,380View SEC Filing Icon  
10/23/2023Thomas Richard KassbergEVPSell39,878$32.78$1,307,200.84246,860View SEC Filing Icon  
10/19/2023Emil D KakkisCEOSell47,853$33.52$1,604,032.56599,743View SEC Filing Icon  
9/7/2023Theodore Alan HuizengaCAOSell2,163$40.80$88,250.4023,614View SEC Filing Icon  
9/5/2023Erik HarrisEVPSell6,000$37.96$227,760.0051,281View SEC Filing Icon  
9/1/2023Theodore Alan HuizengaCAOSell970$37.15$36,035.5023,777View SEC Filing Icon  
6/30/2023Corsee D. SandersDirectorSell585$46.76$27,354.608,985View SEC Filing Icon  
6/19/2023Erik HarrisEVPSell305$48.20$14,701.0057,281View SEC Filing Icon  
6/8/2023Corsee D. SandersDirectorSell1,485$51.65$76,700.259,570View SEC Filing Icon  
5/18/2023John Richard PinionInsiderSell2,012$50.00$100,600.0074,744View SEC Filing Icon  
5/4/2023Karah Herdman ParschauerEVPSell4,378$45.00$197,010.0051,982View SEC Filing Icon  
3/1/2023Camille L. BedrosianEVPSell3,881$45.25$175,615.2546,720View SEC Filing Icon  
3/1/2023Dennis Karl HuangInsiderSell389$45.65$17,757.8575,314View SEC Filing Icon  
2/28/2023Theodore Alan HuizengaCAOSell639$43.40$27,732.6015,558View SEC Filing Icon  
12/21/2022Theodore Alan HuizengaCAOSell2,031$43.96$89,282.7616,197View SEC Filing Icon  
10/14/2022Mardi DierCFOSell1,629$40.16$65,420.6466,695View SEC Filing Icon  
10/12/2022Mardi DierCFOSell3,484$38.22$133,158.4868,324View SEC Filing Icon  
6/19/2022Erik HarrisEVPSell295$54.78$16,160.1036,160View SEC Filing Icon  
4/16/2022Theodore Alan HuizengaCAOSell132$84.55$11,160.6016,914View SEC Filing Icon  
3/11/2022Thomas Richard KassbergEVPSell10,281$67.01$688,929.81View SEC Filing Icon  
3/7/2022Karah Herdman ParschauerEVPSell5,140$62.95$323,563.00View SEC Filing Icon  
3/1/2022Erik HarrisEVPSell2,713$66.62$180,740.06View SEC Filing Icon  
3/1/2022John Richard PinionInsiderSell4,498$66.62$299,656.76View SEC Filing Icon  
1/30/2022Camille L. BedrosianEVPSell1,657$66.30$109,859.10View SEC Filing Icon  
10/14/2021Camille L. BedrosianEVPSell359$81.14$29,129.26View SEC Filing Icon  
10/14/2021John Richard PinionInsiderSell358$81.14$29,048.12View SEC Filing Icon  
10/14/2021Mardi DierCFOSell3,261$81.16$264,662.76View SEC Filing Icon  
10/14/2021Theodore Alan HuizengaCAOSell140$81.14$11,359.60View SEC Filing Icon  
10/12/2021Mardi DierCFOSell3,477$82.79$287,860.83View SEC Filing Icon  
9/8/2021Karah Herdman ParschauerEVPSell7,336$100.65$738,368.4036,004View SEC Filing Icon  
9/1/2021Camille L. BedrosianEVPSell2,500$100.03$250,075.00View SEC Filing Icon  
7/6/2021Erik HarrisEVPSell375$91.53$34,323.75View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ultragenyx Pharmaceutical (NASDAQ:RARE)

97.67% of Ultragenyx Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RARE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ultragenyx Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/28/2024Teachers Retirement System of The State of Kentucky14,792$0.69M0.0%N/A0.018%Search for SEC Filing on Google Icon
5/24/2024Farallon Capital Management LLC99,000$4.62M0.0%N/A0.119%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.177,932$8.31M0.2%N/A0.214%Search for SEC Filing on Google Icon
5/17/2024Motley Fool Asset Management LLC146,526$6.84M0.4%-2.0%0.176%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System74,413$3.47M0.0%-3.5%0.090%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.687,619$32.11M0.1%-4.4%0.827%Search for SEC Filing on Google Icon
5/16/2024Bayesian Capital Management LP15,302$0.71M0.1%N/A0.018%Search for SEC Filing on Google Icon
5/15/2024First Light Asset Management LLC790,446$36.91M2.8%+6.1%0.951%Search for SEC Filing on Google Icon
5/15/2024Public Employees Retirement System of Ohio30,074$1.40M0.0%-8.6%0.036%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD3,568,873$166.63M0.0%+3.5%4.293%Search for SEC Filing on Google Icon
5/15/2024BOKF NA6,736$0.32M0.0%N/A0.008%Search for SEC Filing on Google Icon
5/15/2024Avoro Capital Advisors LLC830,000$38.75M0.5%+137.1%0.998%Search for SEC Filing on Google Icon
5/15/2024Lazard Asset Management LLC4,160$0.19M0.0%+140.9%0.005%Search for SEC Filing on Google Icon
5/14/2024Pitcairn Co.7,957$0.37M0.0%-7.9%0.010%Search for SEC Filing on Google Icon
5/14/2024CANADA LIFE ASSURANCE Co27,461$1.28M0.0%-5.0%0.033%Search for SEC Filing on Google Icon
5/13/2024Clearbridge Investments LLC2,400,854$112.10M0.1%+0.7%2.888%Search for SEC Filing on Google Icon
5/13/2024Seven Eight Capital LP47,556$2.22M0.2%+3.6%0.057%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.8,700,007$406.20M0.0%+0.3%10.465%Search for SEC Filing on Google Icon
5/9/2024Mitsubishi UFJ Asset Management Co. Ltd.6,051$0.28M0.0%-4.3%0.007%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System87,673$4.09M0.0%+2.5%0.105%Search for SEC Filing on Google Icon
5/8/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.507,095$23.68M0.1%+513.8%0.610%Search for SEC Filing on Google Icon
5/8/2024Motley Fool Asset Management LLC144,920$6.77M0.2%-3.0%0.174%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC6,074$0.28M0.0%+8.7%0.007%Search for SEC Filing on Google Icon
5/8/2024US Bancorp DE7,143$0.33M0.0%+5.8%0.009%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.163,141$7.62M0.0%-18.7%0.196%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC594$28K0.0%N/A0.001%Search for SEC Filing on Google Icon
5/7/2024Sei Investments Co.65,996$3.08M0.0%+0.9%0.079%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC23,005$1.07M0.1%N/A0.028%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank145,852$6.81M0.0%+3.0%0.176%Search for SEC Filing on Google Icon
5/6/2024Duality Advisers LP39,977$1.87M0.2%+1.5%0.048%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP10,549$0.49M0.0%N/A0.013%Search for SEC Filing on Google Icon
5/2/2024Nordea Investment Management AB45,043$2.11M0.0%-0.9%0.054%Search for SEC Filing on Google Icon
5/1/2024Capstone Investment Advisors LLC4,863$0.23M0.0%N/A0.006%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets19,893$0.93M0.0%-87.4%0.024%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.230,767$10.78M0.0%+113.0%0.278%Search for SEC Filing on Google Icon
4/30/2024Privium Fund Management B.V.215,102$10.04M2.7%+29.2%0.261%Search for SEC Filing on Google Icon
4/30/2024Allspring Global Investments Holdings LLC3,318$0.16M0.0%+67.7%0.004%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.15,977$0.75M0.0%-4.4%0.019%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.15,817$0.74M0.1%+66.5%0.019%Search for SEC Filing on Google Icon
4/25/2024WCM Investment Management LLC152,500$7.12M0.0%+26.0%0.185%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.142,174$6.64M0.0%-0.3%0.173%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC3,318$0.16M0.0%+67.7%0.004%Search for SEC Filing on Google Icon
4/17/2024Hennion & Walsh Asset Management Inc.49,537$2.31M0.1%+40.0%0.060%Search for SEC Filing on Google Icon
4/9/2024Woodstock Corp11,124$0.52M0.1%+38.0%0.014%Search for SEC Filing on Google Icon
4/5/2024GAMMA Investing LLC1,004$47K0.0%+622.3%0.001%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.8,673,432$414.76M0.0%+19.9%10.534%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP4,415,029$211.13M0.0%-15.0%5.362%Search for SEC Filing on Google Icon
2/20/2024Quarry LP2,200$0.11M0.0%-47.6%0.003%Search for SEC Filing on Google Icon
2/15/2024Great Point Partners LLC648,000$30.99M5.3%-10.9%0.789%Search for SEC Filing on Google Icon
2/14/2024First Light Asset Management LLC744,665$35.61M2.9%-33.8%0.907%Search for SEC Filing on Google Icon
2/14/2024Avidity Partners Management LP844,500$40.38M1.5%+55.2%1.028%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC350,000$16.74M0.2%-76.7%0.426%Search for SEC Filing on Google Icon
2/14/2024Ghisallo Capital Management LLC10,000$0.48M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/14/2024Seven Eight Capital LP45,906$2.20M0.3%+140.7%0.056%Search for SEC Filing on Google Icon
2/14/2024RTW Investments LP6,887,086$329.34M5.2%+27.4%8.388%Search for SEC Filing on Google Icon
2/14/2024Angeles Investment Advisors LLC4,447$0.21M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC1,378$66K0.0%-61.4%0.002%Search for SEC Filing on Google Icon
2/13/2024First Trust Advisors LP1,163,077$55.62M0.1%-3.2%1.416%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC221,910$10.61M0.0%+21.2%0.270%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC10,797$0.52M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/13/2024The Manufacturers Life Insurance Company272,339$13.02M0.0%+13.1%0.332%Search for SEC Filing on Google Icon
2/13/2024Sands Capital Management LLC4,118,008$196.92M0.6%+59.8%5.015%Search for SEC Filing on Google Icon
2/12/2024Treasurer of the State of North Carolina34,853$1.67M0.0%+17.3%0.042%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc221,360$10.59M0.0%+7.8%0.270%Search for SEC Filing on Google Icon
2/12/2024Pier 88 Investment Partners LLC20,590$0.99M0.2%+76.3%0.025%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.214,738$10.27M0.0%+13.3%0.262%Search for SEC Filing on Google Icon
2/9/2024GW&K Investment Management LLC307,529$14.71M0.1%-1.1%0.375%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP53,500$2.56M0.1%+81.1%0.065%Search for SEC Filing on Google Icon
2/9/2024Clearbridge Investments LLC2,383,492$113.98M0.1%+3.9%2.903%Search for SEC Filing on Google Icon
2/9/2024Norges Bank770,506$36.85M0.0%N/A0.938%Search for SEC Filing on Google Icon
2/8/2024Great Lakes Advisors LLC27,773$1.33M0.0%-49.9%0.034%Search for SEC Filing on Google Icon
2/8/2024EFG Asset Management North America Corp.68,468$3.27M0.6%+18.2%0.083%Search for SEC Filing on Google Icon
2/8/2024Mitsubishi UFJ Asset Management Co. Ltd.6,325$0.30M0.0%+13.6%0.008%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.16,707$0.80M0.0%-5.2%0.020%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets157,281$7.52M0.0%-26.6%0.192%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas16,578$0.79M0.0%-17.4%0.020%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.11,871$0.57M0.0%+26.2%0.014%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.471,825$22.56M0.0%+18.9%0.575%Search for SEC Filing on Google Icon
2/6/2024Maryland State Retirement & Pension System6,111$0.29M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/6/2024M&T Bank Corp6,486$0.31M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank15,716$0.75M0.0%+10.0%0.019%Search for SEC Filing on Google Icon
2/6/2024Natixis Advisors L.P.15,289$0.73M0.0%+10.8%0.019%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank141,552$6.77M0.0%-9.1%0.172%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.10,565$0.51M0.0%+44.6%0.013%Search for SEC Filing on Google Icon
2/5/2024Certuity LLC9,145$0.44M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/5/2024Van ECK Associates Corp1,578$75K0.0%+34.0%0.002%Search for SEC Filing on Google Icon
2/5/2024Sector Gamma AS102,490$4.90M1.2%-11.0%0.125%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.200,615$9.59M0.0%+9.1%0.244%Search for SEC Filing on Google Icon
2/2/2024Motley Fool Wealth Management LLC164,235$7.86M0.4%-2.4%0.200%Search for SEC Filing on Google Icon
2/2/2024Truist Financial Corp11,723$0.56M0.0%-38.3%0.014%Search for SEC Filing on Google Icon
2/2/2024Motley Fool Asset Management LLC149,443$7.15M0.5%-4.3%0.182%Search for SEC Filing on Google Icon
2/2/2024State of New Jersey Common Pension Fund D65,068$3.11M0.0%-4.8%0.079%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund72,866$3.48M0.0%+37.0%0.089%Search for SEC Filing on Google Icon
2/1/2024Duality Advisers LP39,371$1.88M0.2%+45.6%0.048%Search for SEC Filing on Google Icon
2/1/2024EFG Asset Management Americas Corp.5,274$0.25M0.1%N/A0.006%Search for SEC Filing on Google Icon
2/1/2024Signaturefd LLC677$32K0.0%-26.2%0.001%Search for SEC Filing on Google Icon
1/31/2024abrdn plc141,117$6.75M0.0%N/A0.172%Search for SEC Filing on Google Icon
1/31/2024Xponance Inc.10,162$0.49M0.0%+6.8%0.012%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.2,446,500$116.99M0.3%+11.4%2.980%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank16,147$0.77M0.0%+14.2%0.020%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ultragenyx Pharmaceutical logo
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc.; Solid Biosciences Inc.; Regeneron; Abeona; and Daiichi Sankyo Co., Ltd. The company was incorporated in 2010 and is headquartered in Novato, California.
Read More on Ultragenyx Pharmaceutical

Today's Range

Now: $39.36
Low: $39.13
High: $40.10

50 Day Range

MA: $41.55
Low: $37.42
High: $45.11

52 Week Range

Now: $39.36
Low: $31.52
High: $54.56

Volume

544,790 shs

Average Volume

803,128 shs

Market Capitalization

$3.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.6

Who are the company insiders with the largest holdings of Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical's top insider shareholders include:
  1. Emil D Kakkis (CEO)
  2. Thomas Richard Kassberg (EVP)
  3. John Richard Pinion (Insider)
  4. Dennis Karl Huang (Insider)
  5. Mardi Dier (CFO)
  6. Karah Herdman Parschauer (EVP)
  7. Erik Harris (EVP)
  8. Eric Crombez (EVP)
  9. Camille L Bedrosian (EVP)
  10. Theodore Alan Huizenga (CAO)
  11. Matthew K Fust (Director)
  12. Corazon (Corsee) D Sanders (Director)
Learn More about top insider investors at Ultragenyx Pharmaceutical.

Who are the major institutional investors of Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical's top institutional investors include:
  1. Vanguard Group Inc. — 10.47%
  2. Price T Rowe Associates Inc. MD — 4.29%
  3. Clearbridge Investments LLC — 2.89%
  4. Avoro Capital Advisors LLC — 1.00%
  5. First Light Asset Management LLC — 0.95%
  6. Jacobs Levy Equity Management Inc. — 0.83%
Learn More about top institutional investors of Ultragenyx Pharmaceutical stock.

Which major investors are selling Ultragenyx Pharmaceutical stock?

During the last quarter, RARE stock was sold by these institutional investors:
  1. BNP Paribas Financial Markets
  2. Russell Investments Group Ltd.
  3. Jacobs Levy Equity Management Inc.
  4. Motley Fool Asset Management LLC
  5. Walleye Trading LLC
  6. Motley Fool Asset Management LLC
  7. Public Employees Retirement System of Ohio
  8. California State Teachers Retirement System
During the previous year, company insiders that have sold Ultragenyx Pharmaceutical company stock include:
  1. Emil D Kakkis (CEO)
  2. Thomas Richard Kassberg (EVP)
  3. John Richard Pinion (Insider)
  4. Dennis Karl Huang (Insider)
  5. Mardi Dier (CFO)
  6. Karah Herdman Parschauer (EVP)
  7. Erik Harris (EVP)
  8. Eric Crombez (EVP)
  9. Camille L Bedrosian (EVP)
Learn More investors selling Ultragenyx Pharmaceutical stock.

Which major investors are buying Ultragenyx Pharmaceutical stock?

During the last quarter, RARE stock was purchased by institutional investors including:
  1. Avoro Capital Advisors LLC
  2. BNP PARIBAS ASSET MANAGEMENT Holding S.A.
  3. Artal Group S.A.
  4. Mirae Asset Global Investments Co. Ltd.
  5. Price T Rowe Associates Inc. MD
  6. Farallon Capital Management LLC
  7. Privium Fund Management B.V.
  8. First Light Asset Management LLC